Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of the Rheumatic Diseases|April 1, 2008
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitisM K de Vries, I E van der Horst-Bruinsma, M T Nurmohamed, et al.
Seminars in Arthritis and Rheumatism|November 26, 2022
In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort studyR Raadsen, R Agca, M Boers, et al.
Rheumatology International|August 11, 2020
The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritisI A M van den Oever, M Baniaamam, S Simsek, et al.
European Journal of Endocrinology|September 6, 2013
Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patientsH G Raterman, A E Voskuyl, S Simsek, et al.
Annals of the Rheumatic Diseases|February 23, 2007
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritisM J L Peters, M Vis, V P van Halm, et al.
Annals of the Rheumatic Diseases|April 29, 2006
Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitisV P van Halm, J C van Denderen, M J L Peters, et al.
Arthritis and Rheumatism|May 1, 2009
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitisI C van Eijk, M K de Vries, J H M Levels, et al.
Annals of the Rheumatic Diseases|August 14, 2008
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE InvestigationV P van Halm, M J L Peters, A E Voskuyl, et al.
Annals of the Rheumatic Diseases|September 24, 2009
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisM J L Peters, D P M Symmons, D McCarey, et al.
Annals of the Rheumatic Diseases|October 5, 2016
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 updateR Agca, S C Heslinga, S Rollefstad, et al.
Pageof 2